Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania, established in 1982, is a non-profit organization that fosters technological innovation and growth in the region. It primarily invests in early-stage technology companies, having supported over 1,750 such ventures since its inception. The organization also facilitates university-industry partnerships to accelerate scientific discoveries to market, and initiates regional programs to bolster the entrepreneurial ecosystem. Its mission is to create jobs and transform lives by leading the region's technology community to new heights.

Jonathan Beschen

Investment Director, Information Technology Investment Group

Anthony George

Venture Capital Associate, Tech Investment Group

Adare McMillan

CFO

Omar Mencin

Managing Director, Information Technology Investment Group

Scott Nissenbaum

President, CEO and Board Member

Aston Pierce

Director - GO PA Fund and GO PHL Fund

Kathie Jordan Ph.D

Managing Director, Healthcare Investment Group

Past deals in Nanotechnology

Avisi Technologies

Seed Round in 2022
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

Avisi Technologies

Seed Round in 2021
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

Avisi Technologies

Seed Round in 2019
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.